AI Article Synopsis
- - SGLT-2 inhibitors are a type of medication that can significantly benefit patients with type 2 diabetes, not just by lowering blood sugar levels but also through other health improvements.
- - These drugs have been shown to enhance heart and kidney health, which is crucial since people with type 2 diabetes are at a greater risk for heart and kidney problems.
- - Ongoing research may lead to even more uses for SGLT-2 inhibitors, as clinical trials continue to explore their full potential.
Article Abstract
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are an exceptionally versatile class of medication, and their glycemic and nonglycemic benefits could help millions of patients with type 2 diabetes. Of note, they have been shown to improve cardiac and renal outcomes, much-needed benefits in patients with type 2 diabetes, who are at a higher risk for developing cardiac and renal dysfunction than those who do not have diabetes. The indications for SGLT-2 inhibitors may continue to expand as ongoing clinical trials provide more insight into these drugs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3949/ccjm.88a.20088 | DOI Listing |
Publication Analysis
Top Keywords
sglt-2 inhibitors
12
type diabetes
12
patients type
8
cardiac renal
8
role sglt-2
4
inhibitors managing
4
managing type
4
diabetes
4
diabetes sodium-glucose
4
sodium-glucose cotransporter-2
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!